CXCR2 and cancer: When adjusted for endometrial thickness above 5 mm, GA heterozygotes in the CXCR2 polymorphism were associated with about double the risk of cancer in the overdominant model (OR 2.23 95% CI 1.03–4.83, p = 0.038).